Literature DB >> 17484277

Design, synthesis and molecular modelling of 1-amidinopiperidine thrombin inhibitors.

I Smolnikar1, A Perdih, M Stegnar, A Prezelj, T Solmajer, U Urleb, A Obreza.   

Abstract

Design, synthesis and biochemical evaluation of a series of novel non-covalent thrombin inhibitors with a 1-amidinopiperidine moiety are presented. Replacement of the planar benzamidine group in azaphenylalanine derivatives with 1-amidinopiperidine resulted in lower activity but higher selectivity for this type of compounds. The binding conformation of inhibitors in the active site of thrombin was revealed by molecular modelling studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484277

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  A Putative Serine Protease is Required to Initiate the RIPK3-MLKL-Mediated Necroptotic Death Pathway in Neutrophils.

Authors:  Xiaoliang Wang; Damjan Avsec; Aleš Obreza; Shida Yousefi; Irena Mlinarič-Raščan; Hans-Uwe Simon
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

2.  Selective cytotoxicity of amidinopiperidine based compounds towards Burkitt's lymphoma cells involves proteasome inhibition.

Authors:  Martina Gobec; Ales Obreza; Matevz Prijatelj; Boris Brus; Stanislav Gobec; Irena Mlinaric-Rascan
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.